Assessment of a New Enhanced Xenograft in Open Maxillary Sinus Augmentation
Recruiting
Phase 2
Phase 3
Interventional Study
Maxillary Sinus Floor Augmentation
Maxillary Sinus Elevation
Bone Augmentation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Misr International University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Implant supported dental restorations are sometimes challenging with decreased bone height in the posterior maxilla. The goal of this study is to test an augmentation bone substitute in elevating the maxillary sinus floor; in terms of soft tissue reaction, formed bone height as well as structure.
Bone substitute will be compared to a graftless method of bone augmentation depending on participants…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult male/female patients above the age of 18.
* Patients with one or more teeth requiring implant supported dental restoration in atrophic posterior maxilla.
* Alveolar bone height less than 5 mm at the defective site.
* Good oral hygiene.
* Patient's consensual agreement to…
Contacts